Skip to content
CA.gov logo in white
  • Grants Management System
  • CIRM Hub Portal
  • Contact
  • About
    • Our Mission
    • Our Impact
    • Our Governing Board
    • Strategic Goals
    • Our Team
    • Annual Reports
  • For Researchers
    • Funding Opportunities
    • Information for Applicants
    • Researcher Resources
    • Our Review Process
  • Our Programs
    • Grants Dashboard
    • Research and Development
    • Education and Training
    • Patient Access
  • Patient Resources
    • Stem Cell and Genetic Research
    • From Bench to Bedside
    • Community Outreach
    • Clinical Trials
    • Community Stories
  • News and Events
    • Press Releases
    • Public Meetings
    • Blog
    • Webinars and Workshops
  • About
    • Our Mission
    • Our Impact
    • Our Governing Board
    • Strategic Goals
    • Our Team
    • Annual Reports
  • For Researchers
    • Funding Opportunities
    • Information for Applicants
    • Researcher Resources
    • Our Review Process
  • Our Programs
    • Grants Dashboard
    • Research and Development
    • Education and Training
    • Patient Access
  • Patient Resources
    • Stem Cell and Genetic Research
    • From Bench to Bedside
    • Community Outreach
    • Clinical Trials
    • Community Stories
  • News and Events
    • Press Releases
    • Public Meetings
    • Blog
    • Webinars and Workshops

Kidney and Blood Stem Cell Transplantation That Eliminates Requirement for Immunosuppressive Drugs

  • Post author:
  • Post published:March 18, 2026
  • Post category:

Continue ReadingKidney and Blood Stem Cell Transplantation That Eliminates Requirement for Immunosuppressive Drugs

A Study of GDX012 in Adults With Relapsed or Refractory Acute Myeloid Leukemia

  • Post author:
  • Post published:March 17, 2026
  • Post category:

Continue ReadingA Study of GDX012 in Adults With Relapsed or Refractory Acute Myeloid Leukemia

A Study of CC-95266 in Participants With Relapsed and/or Refractory Multiple Myeloma

  • Post author:
  • Post published:March 17, 2026
  • Post category:

Continue ReadingA Study of CC-95266 in Participants With Relapsed and/or Refractory Multiple Myeloma

Brain Tumor-Specific Immune Cells (IL13Ralpha2-CAR T Cells) for the Treatment of Leptomeningeal Glioblastoma, Ependymoma, or Medulloblastoma

  • Post author:
  • Post published:March 17, 2026
  • Post category:

Continue ReadingBrain Tumor-Specific Immune Cells (IL13Ralpha2-CAR T Cells) for the Treatment of Leptomeningeal Glioblastoma, Ependymoma, or Medulloblastoma

A Phase 1/2 Trial of ADI-270 in ccRCC

  • Post author:
  • Post published:March 17, 2026
  • Post category:

Continue ReadingA Phase 1/2 Trial of ADI-270 in ccRCC

A Vaccine (Neoantigen-Targeted ppDC) for the Treatment of H3 G34-mutant Diffuse Hemispheric Glioma

  • Post author:
  • Post published:March 12, 2026
  • Post category:

Continue ReadingA Vaccine (Neoantigen-Targeted ppDC) for the Treatment of H3 G34-mutant Diffuse Hemispheric Glioma

Study of Gene Therapy Using a Lentiviral Vector to Treat X-linked Chronic Granulomatous Disease

  • Post author:
  • Post published:March 1, 2026
  • Post category:

Continue ReadingStudy of Gene Therapy Using a Lentiviral Vector to Treat X-linked Chronic Granulomatous Disease

CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells With or Without NKTR-255 in Adults With Recurrent or Refractory B Cell Malignancies

  • Post author:
  • Post published:March 1, 2026
  • Post category:

Continue ReadingCD19/CD22 Chimeric Antigen Receptor (CAR) T Cells With or Without NKTR-255 in Adults With Recurrent or Refractory B Cell Malignancies

Depleted Donor Stem Cell Transplant in Children and Adults With Fanconi Anemia After Being Conditioned With a Regimen Containing Briquilimab

  • Post author:
  • Post published:March 1, 2026
  • Post category:

Continue ReadingDepleted Donor Stem Cell Transplant in Children and Adults With Fanconi Anemia After Being Conditioned With a Regimen Containing Briquilimab

CD19-specific CAR T Cells With a Fully Human Binding Domain for CD19+ Leukemia or Lymphoma

  • Post author:
  • Post published:March 1, 2026
  • Post category:

Continue ReadingCD19-specific CAR T Cells With a Fully Human Binding Domain for CD19+ Leukemia or Lymphoma
  • Go to the previous page
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • Go to the next page
  • Careers
  • Administrative & Financials
  • Accessibility

Subscribe to Receive CIRM News

Get the latest CIRM news, information on upcoming meetings, and funding opportunities delivered to your inbox. 

Sign Up
Facebook-f X-twitter Instagram Linkedin Youtube
  • Privacy Policy
  • ©2025 California Institute for Regenerative Medicine
  • Media Guidelines
  • Contact Us